EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)
EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: EPIOXA CROSS-LINKING; Generic name: RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC; Manufacturer: Glaukos Corporation.
| Brand name | EPIOXA CROSS-LINKING |
|---|---|
| Generic name | RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC |
| Manufacturer | Glaukos Corporation |
| Used for | 1 INDICATIONS AND USAGE EPIOXA HD and EPIOXA are indicated in epithelium-on corneal collagen cross-linking for the treatment of keratoconus in adults and pediatric patients aged 13 years and older, in conjunction with the O 2 n System and the Boost Goggles. EPIOXA HD and EPIOXA are photoenhancers indicated for use in epithelium-on corneal collagen cross-linking for the treatment of keratoconus in adults and pediatric patients aged 13 years and older, in conjunction with the O 2 n System and the Boost Goggles ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Apply topical anesthetic and insert a lid speculum ( 2 ). Using a cellulose spear sponge soaked with EPIOXA HD, remove the mucin layer from the corneal surface without debriding the corneal epithelium (epithelium-on) by swiping the sponge 4 to 10 times horizontally and vertically ( 2 ). Apply two drops of EPIOXA HD topically on the eye every 60 seconds for 4 minutes (STEP 1), followed by two drops of EPIOXA topically on the eye every 30 seconds for 6 minutes (STEP 2) |
| Route | OPHTHALMIC |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13cefc46-337c-41a3-b113-106bfe553bbb |